Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE:PRO)

Morocco · Delayed Price · Currency is MAD

1,480.00

+82.00 (5.87%)

At close: Sep 18, 2026

Market Cap	1.48B +3.5%
Revenue (ttm)	979.73M +9.0%
Net Income	59.91M +8.6%
EPS	59.91 +8.6%
Shares Out	1.00M
PE Ratio	24.70
Forward PE	n/a
Dividend	30.00 (2.03%)
Ex-Dividend Date	Sep 11, 2026

Volume	19
Open	1,480.00
Previous Close	1,398.00
Day's Range	1,480.00 - 1,480.00
52-Week Range	1,223.00 - 1,589.00
Beta	-0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 28, 2026

About CBSE:PRO

Societe de Promotion Pharmaceutique du Maghreb S.A. manufactures and markets pharmaceutical and dermo-cosmetic products in the United States, Canada, and internationally. It provides its products for therapeutic areas, including respiratory, oncology, and pain management. It also offers injectable, and oral and respiratory manufacturing capabilities. The company was founded in 1947 and is based in Casablanca, Morocco. Societe de Promotion Pharmaceutique du Maghreb S.A. is a subsidiary of Hikma Pharmaceuticals PLC. [Read more]

Industry Pharmaceutical Preparations

Founded 1947

Employees 343

Stock Exchange Casablanca Stock Exchange

Ticker Symbol PRO

Full Company Profile

Financial Performance

In 2025, CBSE:PRO's revenue was 979.73 million, an increase of 9.02% compared to the previous year's 898.71 million. Earnings were 59.91 million, an increase of 8.62%.

Financial Statements